This book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector. Scientific and technical staff must work closely with supply-chain practitioners and other relevant parties to help secure responsive, cost effective and risk mitigated supply chains to compete on a world stage. This should not wait until a drug has been registered, but should start as early as possible in the development process and before registration or clinical trials. The author suggests that CMC (chemistry manufacturing controls) drug development must reset the line of sight – from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. Capable processes and suppliers, streamlined logistics, flexible plant and equipment, shorter cycle times, effective flow of information and reduced waste. All these factors can and should be addressed at the CMC development stage.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Hedley Rees runs the independent consulting company Biotech PharmaFlow, which specializes in pharmaceutical supply chain management. He has been actively building, managing, and continuously improving supply chains in biotech for the last fifteen years.
"...[This] interesting exploration of SCM issues includes business, control, regulatory and technical aspects. . . .a must-read for those entering into the SCM fields as well as all those who intersect with SCM."
―Bob Coleman, former FDA Investigator and current Senior Compliance Expert, IHL Consulting Group, Inc.
A timely guide for improving productivity, driving out cost, aising quality
In response to the global pressure to contain healthcare budgets while improving compliance, the pharmaceutical industry is moving supply chain center stage, in an attempt to build supply chains comparable with the aerospace, semi-conductor, electronics, and automotive industries. This book bridges the gap between practitioners of supply chain management and pharmaceutical industry experts. It shows them how to jointly contribute to meaningful improvements in supply chains within the pharmaceutical sector.
Supply Chain Management in the Drug Industry suggests that CMC (chemistry, manufacturing, and controls) drug development must reset the line of sight―from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. In addition, the book:
Provides a practical guide to the application of supply chain management (SCM) processes and practices in the pharmaceutical setting
Stresses the importance of integrated SCM throughout a pharmaceutical organization
Encourages the critical need for cultural shift and fosters collaborations between SCM practitioners and pharmaceutical scientists
With a thorough exploration of SCM from beginning to end of the pharmaceutical process, this book helps secure responsive, cost effective, and risk mitigated supply chains to compete on a world stage.
"...[This] interesting exploration of SCM issues includes business, control, regulatory and technical aspects. . . .a must-read for those entering into the SCM fields as well as all those who intersect with SCM."
—Bob Coleman, former FDA Investigator and current Senior Compliance Expert, IHL Consulting Group, Inc.
A timely guide for improving productivity, driving out cost, aising quality
In response to the global pressure to contain healthcare budgets while improving compliance, the pharmaceutical industry is moving supply chain center stage, in an attempt to build supply chains comparable with the aerospace, semi-conductor, electronics, and automotive industries. This book bridges the gap between practitioners of supply chain management and pharmaceutical industry experts. It shows them how to jointly contribute to meaningful improvements in supply chains within the pharmaceutical sector.
Supply Chain Management in the Drug Industry suggests that CMC (chemistry, manufacturing, and controls) drug development must reset the line of sight—from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. In addition, the book:
Provides a practical guide to the application of supply chain management (SCM) processes and practices in the pharmaceutical setting
Stresses the importance of integrated SCM throughout a pharmaceutical organization
Encourages the critical need for cultural shift and fosters collaborations between SCM practitioners and pharmaceutical scientists
With a thorough exploration of SCM from beginning to end of the pharmaceutical process, this book helps secure responsive, cost effective, and risk mitigated supply chains to compete on a world stage.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: WorldofBooks, Goring-By-Sea, WS, Vereinigtes Königreich
Hardback. Zustand: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged. Bestandsnummer des Verkäufers GOR005937579
Anzahl: 1 verfügbar
Anbieter: WeBuyBooks, Rossendale, LANCS, Vereinigtes Königreich
hardcover. Zustand: Very Good. Most items will be dispatched the same or the next working day. A copy that has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged. Bestandsnummer des Verkäufers rev4827965166
Anzahl: 1 verfügbar
Anbieter: World of Books (was SecondSale), Montgomery, IL, USA
Hardback. Zustand: Good. This book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector. Scientific and technical staff must work closely with supply-chain practitioners and other relevant parties to help secure responsive, cost effective and risk mitigated supply chains to compete on a world stage. This should not wait until a drug has been registered, but should start as early as possible in the development process and before registration or clinical trials. The author suggests that CMC (chemistry manufacturing controls) drug development must reset the line of sight - from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. Capable processes and suppliers, streamlined logistics, flexible plant and equipment, shorter cycle times, effective flow of information and reduced waste. All these factors can and should be addressed at the CMC development stage. Bestandsnummer des Verkäufers CIN0470555173G
Anzahl: 1 verfügbar
Anbieter: World of Books Inc, Montgomery, IL, USA
Hardback. Zustand: Good. This book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector. Scientific and technical staff must work closely with supply-chain practitioners and other relevant parties to help secure responsive, cost effective and risk mitigated supply chains to compete on a world stage. This should not wait until a drug has been registered, but should start as early as possible in the development process and before registration or clinical trials. The author suggests that CMC (chemistry manufacturing controls) drug development must reset the line of sight - from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. Capable processes and suppliers, streamlined logistics, flexible plant and equipment, shorter cycle times, effective flow of information and reduced waste. All these factors can and should be addressed at the CMC development stage. Bestandsnummer des Verkäufers CIN0470555173G
Anzahl: 1 verfügbar
Anbieter: clickgoodwillbooks, Indianapolis, IN, USA
Zustand: acceptable. Used - Acceptable: All pages and the cover are intact, but shrink wrap, dust covers, or boxed set case may be missing. Pages may include limited notes, highlighting, or minor water damage but the text is readable. Item may be missing bundled media. Bestandsnummer des Verkäufers 3O6WBH001F3L_ns
Anzahl: 1 verfügbar
Anbieter: Studibuch, Stuttgart, Deutschland
hardcover. Zustand: Gut. 458 Seiten; 9780470555170.3 Gewicht in Gramm: 2. Bestandsnummer des Verkäufers 1121397
Anzahl: 1 verfügbar
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers FW-9780470555170
Anzahl: 15 verfügbar
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Zustand: new. Bestandsnummer des Verkäufers e55c9b9a4c1bf715f321ef6b4ed6bee4
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New. Bestandsnummer des Verkäufers 6299625-n
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition. Bestandsnummer des Verkäufers 6299625
Anzahl: Mehr als 20 verfügbar